(S,R)-Mefloquine

(S,R)-Mefloquine

SCHEMBL32385911

O[C@@H](c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)[C@H]1CCCCN1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 8/20 1.00
▸ CYP2D6 P10635 6/20 1.00
▸ ADORA2A P29274 5/20 1.00
▸ ADORA1 P30542 5/20 1.00
▸ CYP3A4 P08684 4/20 1.00
▸ CYP1A2 P05177 4/20 1.00
▸ CYP2C19 P33261 3/20 1.00
▸ ADORA3 P0DMS8 2/20 1.00
▸ ADORA2B P29275 1/20 1.00
▸ ABCG2 Q9UNQ0 1/20 1.00
▸ KDM4E B2RXH2 1/20 1.00
▸ NR1I2 O75469 1/20 1.00
▸ LMNA P02545 1/20 1.00
▸ TP53 P04637 1/20 1.00
▸ HTR1A P08908 1/20 1.00
▸ TSHR P16473 1/20 1.00
▸ CNR1 P21554 1/20 1.00
▸ GLRA1 P23415 1/20 1.00
▸ SLC6A2 P23975 1/20 1.00
▸ HTR2A P28223 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Mefloquine SCHEMBL7130867 1.00 KCNH2 (1.00) KCNH2CYP2D6ADORA2AADORA1CYP3A4
Mefloquine SCHEMBL21782 1.00 KCNH2 (1.00) KCNH2CYP2D6ADORA2AADORA1CYP3A4
(S,S)-Mefloquine SCHEMBL7278974 1.00 KCNH2 (1.00) KCNH2CYP2D6ADORA2AADORA1CYP3A4
(S,R)-Mefloquine SCHEMBL21780 1.00 KCNH2 (1.00) KCNH2CYP2D6ADORA2AADORA1CYP3A4
Mefloquine SCHEMBL3625982 1.00 KCNH2 (1.00) KCNH2CYP2D6ADORA2AADORA1CYP3A4
(S,R)-Mefloquine SCHEMBL16702641 1.00 KCNH2 (1.00) KCNH2CYP2D6ADORA2AADORA1CYP3A4
Mefloquine SCHEMBL8575605 1.00 KCNH2 (1.00) KCNH2CYP2D6ADORA2AADORA1CYP3A4
(R,R)-Mefloquine SCHEMBL21781 1.00 KCNH2 (1.00) KCNH2CYP2D6ADORA2AADORA1CYP3A4
Mefloquine SCHEMBL17087807 1.00 KCNH2 (1.00) KCNH2CYP2D6ADORA2AADORA1CYP3A4
Mefloquine SCHEMBL29433990 1.00 KCNH2 (1.00) KCNH2CYP2D6ADORA2AADORA1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260027215-A1 COMPOSITIONS FOR TRANSPORT OF THERAPEUTIC CARGOS USING BINDERS TARGETING CA-IV RECEPTIVE BIO INC (US) 2026-01-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260027215-A1 COMPOSITIONS FOR TRANSPORT OF THERAPEUTIC CARGOS USING BINDERS TARGETING CA-IV CA4, FLT4, CAMK4 KCNH2 3983/4885CYP2D6 386/4885ADORA2A 1681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback